Lipoxen refocusing

Drug delivery company Lipoxen plc (LSE:LPX) announced plans to refocus its business, in part through the acquisition of cancer company SymbioTec GmbH (Saarbruecken, Germany). Lipoxen also said it plans to raise a total of L14.4 million ($23.7 million) through a placing and open offer. SynBio LLC (Moscow, Russia) will purchase 110.8 million shares at 11p, while Serum Institute of India Ltd. (Pune, India) will purchase 2.5 million shares at 11p. The open offer includes up to 17.7 million shares, with shareholders eligible to purchase a share for every 10 held. ...